). Consistent with the QTL effect, mice lacking C57BL/6 alleles in this region had reduced splenomegaly induced by G-CSF. Intriguingly, peripheral blood neutrophilia and progenitor cell mobilisation responses to G-CSF were also significantly influenced. Leukemia (2000) 14, 657-661.
Introduction
G-CSF is now widely used in normal volunteer donors to mobilise peripheral blood progenitor cells (PBPC) for allogeneic haemopoietic stem cell transplantation. 1 Most attention has focused on the efficiency of the mobilisation response and broad variability among normal subjects in the number of progenitor cells mobilised by standardised regimens of G-CSF is now well documented. [2] [3] [4] [5] [6] [7] [8] Recently, it has become recognised that splenic enlargement is also an in vivo consequence of G-CSF administration. Splenomegaly was first documented in patients with severe chronic neutropenia receiving prolonged courses of G-CSF. 9 More recently, splenomegaly and splenic rupture have been observed in two donors of allogeneic PBPC. 10, 11 Such dramatic splenic enlargement is apparently uncommon. However, the incidence of minor or subclinical enlargement in normal subjects is unknown because studies have relied on clinical assessment, an insensitive method of measurement of splenic size. In contrast, splenic enlargement is a predictable and prominent in vivo response in mice injected with G-CSF. [12] [13] [14] [15] Splenomegaly is due to increased extramedullary haemopoiesis in both species, but varies between species in relative extent. [11] [12] [13] [14] In mice injected with G-CSF, spleen weight increases in parallel with nucleated cell number, 15 with the increased cellularity directly reflecting the dramatic expansion of splenic myelopoiesis. 12, 15, 16 A possible explanation for the variation observed between normal subjects in regard in vivo responses to G-CSF such as splenic enlargement or progenitor cell mobilisation may lie in genetic differences in key systems or steps involved in each process. This hypothesis is difficult to test in humans, but is amenable to investigation in inbred laboratory mice. We have previously reported major quantitative differences between inbred strains of mice in G-CSF-induced responses, including progenitor cell mobilisation, leukocytosis and splenomegaly. 16 These differences were evident over a wide range of G-CSF dosages and were not diminished by prolonged administration of the drug. They were not accompanied by differences in cytokine responsiveness in vitro. These observations strongly suggested that in vivo responses to G-CSF are multigenic (or complex) traits and that the level of response for an individual represents the sum action of a complex mix of multiple genetic and environmental factors.
Responses to cytokines are quantitative, continuous and therefore amenable to genetic dissection using quantitative trait linkage analysis. 17, 18 This approach uses experimental genetic crosses with genome-wide genotype to phenotype correlation to dissect traits which represent the combined action of individual genetic factors into their discrete genetic factors or quantitative trait loci.
Using such an approach, we have identified a locus on murine chromosome 1 which partly determines the magnitude of increase in spleen size induced by G-CSF and which may also be a minor determinant of progenitor cell mobilisation and leukocytosis.
Methods

Mice
The following inbred strains of mice were used in this study:
. B6D2F1 hybrids were generated by breeding female C57BL/6 and male DBA/2 mice, and B6D2F2 mice were derived from matings of these hybrids. All mice were bred under specific pathogen-free conditions. In all experiments, male mice aged 6-8 weeks were used unless otherwise specified.
G-CSF administration
Lyophilized recombinant human G-CSF (rhG-CSF, lenograstim; AMRAD, Melbourne, Australia) was dissolved in sterile water for injection and diluted in sterile normal saline for injection (Delta West, Melbourne, Australia) -5% bovine calf serum (BCS). Mice were weighed prior to the commencement of all experiments. Because F2 mice displayed a broad range of weights (20- 31 g) , the dose of G-CSF was adjusted to ensure the dose received was within 5% of the target dose. Mice were injected with G-CSF 40 g/kg/day intraperitoneally for 5 days. In some experiments G-CSF 200 g/kg/day was used. We and others have previously reported [12] [13] [14] [15] [16] that at these dosages of G-CSF, mice demonstrate similar neutrophilia and progenitor cell mobilisation to that observed in normal humans receiving 5-10 g/kg/day for 5 days. 2 The daily dose was given in two divided doses at 8 am and 6-7 pm each day, and blood and tissues harvested on the morning of the sixth day, 15 h after the final injection.
Parameters of response
Spleen weight, PB white cell count (WCC), and the number of non-erythroid progenitor cells per volume of blood were measured routinely, exactly as previously described. 16 Pokeweed mitogen spleen-conditioned medium (SCM) was used as the culture stimulus in all progenitor cell assays.
Genotyping of mice
Genotyping of mice was performed by multiplex polymerase chain reaction (PCR) as previously described. 19 Polymorphic loci were selected from the Whitehead Institute for Biomedical Research database. 20, 21 Oligonucleotides (Research Genetics Huntsville, AL, USA) for 150 loci polymorphic between parental strains were chosen initially to cover the entire genome at approximately 10 cM (centimorgan) intervals, with later substitutions of additional loci to replace those which did not produce a PCR product.
Quantitative trait locus analysis
Genetic linkage analysis between phenotype and genotype of the F2 generation mice was performed using QTL analysis employing the technique of interval mapping. 17 Genetic maps for each chromosome were constructed from the F2 genotypes using Mapmaker/EXP version 3.0b. 22 The integrity of these maps was assessed by comparisons with published databases. 20, 21, 23 Once map integrity was established, the data were analysed using Mapmaker/QTL version 1.1b. Results are reported as genetic intervals and the statistical support for linkage is reported as logarithm of the odds (LOD) scores by a system recommended by Lander and Kruglyak. 24 Although this report focuses on splenic enlargement, two other traits were analysed simultaneously: leukocytosis and progenitor cell mobilisation. Accordingly, the thresholds for linkage were adjusted for the number of independent traits tested (ie three). For significant linkage, the threshold LOD score was calculated to be 4.8. The probability of generating this LOD score by random chance alone in these particular genome-wide scans was less than 5%. 24 The threshold for suggestive linkage was calculated to be LOD 3.3.
Statistics
Results of bioassays are expressed as means ± standard deviations (s.d.). Student's t-test was used to compare data for responses to G-CSF between two groups. Initial comparisons between multiple groups were made by analysis of variance (ANOVA). Only if the null hypothesis was rejected, P Ͻ 0.01, were further pairwise comparisons performed using the Student-Newman-Keuls test.
Results
Intercross of C57BL/6 and DBA/2
Previously we have reported that spleen size in DBA/2 mice injected with G-CSF is almost twice that of C57BL/6 mice, despite similar spleen weights at baseline. 16 In the current experiments, the mode of inheritance of the high-and lowsplenic response phenotypes of DBA/2 and C57BL/6 mice was studied in F1 and F2 progeny of an intercross between these strains. All mice were injected with G-CSF 40 g/kg/day for 5 days. The weight of B6D2F1 spleens (148 ± 11 mg, n = 14) was similar to those of C57BL/6 mice (143 ± 23 mg, n = 16; P = 0.465) and significantly less than those of DBA/2 mice assayed in parallel (238 ± 54 mg, n = 16; P Ͻ 0.001). In two independent experiments, each involving 96 animals (Figure 1) , mice of the F2 exhibited a broad distribution of induced spleen weights, with the mean value weighted toward the mean level of C57BL/6 mice, the low-response phenotype. This continuous distribution is typical of that observed for multigenic traits.
QTL analysis of G-CSF induced responses
To identify genetic loci responsible for the interstrain differences in response observed between DBA/2 and C57BL/6, linkage analysis of biological phenotype and genotype of F2 mice was performed using the technique of QTL analysis. Analysis of 96 F2 mice in the initial experiment identified a single locus on chromosome 1 with suggestive linkage (LOD 4.4) for spleen weight. To increase the power of the study, a further cohort of 96 F2 mice and controls was injected with G-CSF. Significant linkage (LOD 4.8) for a locus in the same region was also observed when the second cohort of mice was analysed independently. QTL analysis of data from all 192 F2 mice demonstrated highly significant linkage (maximum LOD score of 7.9) to a locus within a 22 cM segment of chromosome 1, demarcated by the markers D1 Figure 1 Spleen weight induced by G-CSF in the parental strains and progeny of intercrosses between C57BL/6 and DBA/2 mice. Left panel, experiment 1, right panel, experiment 2. Mice were injected with G-CSF 40 g/kg/day for 5 days. The spleen weights for individual mice are presented (for F2, n = 96 in each experiment) and the mean for each group is indicated by a straight line.
Mit181 and D1 Mit265 (Figure 2 ). The probability that this result occurred by random chance is less than 0.1%. 24 Counterintuitively, the high-response allele for this locus was the C57BL/6 allele. No other statistically significant loci were identified for spleen weight, leukocytosis or PBPC number.
Confirmation of the relevance of chromosome 1 locus
In order to more accurately map the QTL and also to obtain confirmatory evidence of the relevance of the identified locus to G-CSF responsiveness, congenic strains differing genetically only around this region were studied. C57BL/6 mice carrying isolated DBA/2-derived chromosome 1 segments have not been described, but mice with SJL-derived segments in this region, C57BL/6.SJL-Ptprc a Pep3 b /BoyJ (Ly5.1), were available. SJL mice differ from C57BL/6 in their spleen weight, PBPC and WCC responses to G-CSF. 16 Fine mapping was performed to determine the position and size of the congenic region. C57BL/6.SJL-Ptprc a Pep3 b /BoyJ mice are genetically identical to C57BL/6 except for an approximately 12 cM region on chromosome 1. The proximal and distal markers of this SJL segment were D1Mit308 (62 cM from the centromere 23, 25 ) and D1Mit288 (74 cM from the centromere 23, 25 ) respectively, defining a region wholly encompassed by the interval identified in the B6D2F2 QTL analysis (see Figure 2) . Table 1 summarises the results of spleen weight, PBPC and WCC responses induced in each of the congenic strains by injection of G-CSF at 40 and 200 g/kg/day for 5 days. At both doses, induced spleen weight was greater in C57BL/6 mice as predicted from the QTL analysis, with statistically significant differences clearly evident at the higher dose. Intriguingly, both peripheral blood neutrophil and progenitor cell numbers were also greater in C57BL/6 at both doses, suggesting the congenic region contained a locus or loci that also influenced these phenotypes.
Figure 2
QTL linkage analysis of G-CSF induced spleen weight for chromosome 1. The probability of linkage was determined using MapMaker/QTL and is plotted as a LOD score for each location along chromosome 1. The distances between markers are proportional to the genetic distances, as determined from the genotype data. The chromosomal location of the SJL-derived segment mapped from C57BL/6.SJLPtprc a Pep3 b /BoyJ mice is superimposed and is represented as a black bar. Also superimposed above the black bar is a cM ruler indicating the position of the markers when cross-referenced to the 1999 Chromosome 1 Committee Map. 25 
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Discussion
In vivo responses to G-CSF such as the degree of spleen enlargement and the number of progenitor cells mobilised into the circulation vary from individual to individual, and from mouse strain to mouse strain, in a fashion characteristic of a complex genetic trait. In such traits, the magnitude of these responses for an individual or for a specific mouse strain is determined by the sum action of a mix of high-and lowresponse alleles at multiple genetic loci. 17, 18 We hypothesised that the genetic factors responsible for these differences will include rate-limiting steps and other key determinants involved in these haemopoietic perturbations. The current work describes the first positive results of our attempt to use the power of QTL analysis to identify the genetic loci involved.
The data indicate that the degree of G-CSF-induced splenomegaly is modulated by the gene product of a locus on chromosome 1. This locus does not appear to influence steadystate spleen size because no differences in spleen weight were observed at baseline between either C57BL/6 and DBA/2 mice, and C57BL/6 and congenic C57BL/6.SJL-Ptprc a Pep3 b /BoyJ mice. The finding that the high-response allele for this locus was derived from the phenotypically lowresponding C57BL/6 strain was unexpected, as was the absence of other loci with high-response DBA/2 alleles. While this raises questions as to the sensitivity of the general approach, the veracity of this result is attested by (1) its reproducibility, (2) the highly significant LOD score for the combined data, and (3) the data from strains congenic for part of the implicated chromosomal segment. As judged from the congenic experiments, the importance of this locus in regulating in vivo responses to G-CSF appears to be relatively modest and does not explain the major differences observed between C57BL/6 and DBA/2 strains. Other unidentified genetic loci must also be contributing to the differences. Nonetheless, the identification of a gene which modulates in vivo responses to G-CSF may aid elucidation of the poorly understood feedback mechanisms regulating both production and distribution of blood cells. Study power is the critical determinant of success for the utility of QTL analysis. 18, 24 In the current setting, data from 192 F2 mice have provided insufficient power to resolve the multiple genetic loci involved. To increase the chances of detection of loci with high-response DBA/2 alleles, complementary studies utilizing backcross interbreeding are now being performed. QTL analysis has been applied previously in the discipline of haematology for the identification of genetic regulators of stem cell frequency in the bone marrow. Two groups independently investigated that particular complex trait by measuring in vitro the frequency of putative stem cells in 26 recombinant inbred strains (derived originally from C57BL/6 and DBA/2 mice). [26] [27] [28] Two loci on chromosome 1 with suggestive linkage were reported by Mü ller-Sieburg and Riblet, 26 and de Haan and Van Zant 27 reported a locus on chromosome 18 with significant linkage. As with the locus for splenomegaly, these loci require independent confirmatory evidence.
The locus modulating splenomegaly reported here does not coincide with either of the two loci on chromosome 1 reported to be associated with stem cell frequency. Indeed, Mü ller-Sieburg and Riblet 26 reported the frequency of stem cells in the bone marrow of C57BL/6 and C57BL/6.SJLPtprc a Pep3 b /BoyJ congenic mice to be identical. The current data provide no clue as to the biological function of the pertinent gene product encoded by this locus, and the substantial length of the congenic segment precludes meaningful speculation of the candidacy of known genes mapped to this region. Interestingly, differences in the cycling status of primitive progenitor cells (high proliferative potential-CFC) from the bone marrow of these congenic strains have been noted previously, 29 raising the possibility that the G-CSF-induced phenotypes and the cell-cycling phenotypes are varying manifestations of a single genetic difference. Ultimately identification of the function of the gene product and proof of its role in splenomegaly and other in vivo responses to G-CSF such as progenitor cell mobilisation await the completion of positional cloning efforts.
